<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Mol. Biosci.</journal-id>
<journal-title>Frontiers in Molecular Biosciences</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Mol. Biosci.</abbrev-journal-title>
<issn pub-type="epub">2296-889X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">679548</article-id>
<article-id pub-id-type="doi">10.3389/fmolb.2021.679548</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Molecular Biosciences</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Gene Expression Profile in Immortalized Human Periodontal Ligament Fibroblasts Through hTERT Ectopic Expression: Transcriptome and Bioinformatic Analysis</article-title>
<alt-title alt-title-type="left-running-head">Nogueira et&#x20;al.</alt-title>
<alt-title alt-title-type="right-running-head">Immortalized Human Periodontal Ligament Fibroblasts</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Nogueira</surname>
<given-names>Lygia S.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1307391/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vasconcelos</surname>
<given-names>Carolina P.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mitre</surname>
<given-names>Geovanni Pereira</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bittencourt</surname>
<given-names>Leonardo Oliveira</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1299339/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pla&#xe7;a</surname>
<given-names>Jessica Rodrigues</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kataoka</surname>
<given-names>Maria Sueli da Silva</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pinheiro</surname>
<given-names>Jo&#xe3;o de Jesus Viana</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Garlet</surname>
<given-names>Gustavo Pompermaier</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/55041/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>De Oliveira</surname>
<given-names>Edivaldo H. C.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/524173/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Lima</surname>
<given-names>Rafael R.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/419024/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<label>
<sup>1</sup>
</label>Laboratory of Functional and Structural Biology, Institute of Biological Sciences, Federal University of Par&#xe1;, <addr-line>Bel&#xe9;m</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff2">
<label>
<sup>2</sup>
</label>Laboratory of Cell Culture and Cytogenetics, Environment Section, Evandro Chagas Institute, <addr-line>Ananindeua</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff3">
<label>
<sup>3</sup>
</label>School of Dentistry, Federal University of Par&#xe1;, <addr-line>Bel&#xe9;m</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff4">
<label>
<sup>4</sup>
</label>Regional Blood Center at University Hospital of the Ribeir&#xe3;o Preto Medical School of University of S&#xe3;o Paulo, <addr-line>Ribeir&#xe3;o Preto</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff5">
<label>
<sup>5</sup>
</label>School of Dentistry of Bauru, University of S&#xe3;o Paulo, <addr-line>Bauru</addr-line>, <country>Brazil</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/133767/overview">Prasun K. Datta</ext-link>, Tulane University, United&#x20;States</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1290233/overview">Dmitry Zhdanov</ext-link>, Russian Academy of Medical Sciences (RAMS), Russia</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/665777/overview">Helena Soares</ext-link>, Fac. Ci&#xea;ncias Universidade de Lisboa, Portugal</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Rafael R. Lima, <email>rafalima@ufpa.br</email>
</corresp>
<fn fn-type="other">
<p>This article was submitted to Cellular Biochemistry, a section of the journal Frontiers in Molecular Biosciences</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>01</day>
<month>06</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>8</volume>
<elocation-id>679548</elocation-id>
<history>
<date date-type="received">
<day>26</day>
<month>03</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>04</day>
<month>05</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2021 Nogueira, Vasconcelos, Mitre, Bittencourt, Pla&#xe7;a, Kataoka, Pinheiro, Garlet, De Oliveira and Lima.</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>Nogueira, Vasconcelos, Mitre, Bittencourt, Pla&#xe7;a, Kataoka, Pinheiro, Garlet, De Oliveira and Lima</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these&#x20;terms.</p>
</license>
</permissions>
<abstract>
<p>Human periodontal ligament fibroblast (hPLF) cells play an important role in maintaining oral cavity homeostasis with special function in tissue regeneration and maintenance of dental alveoli. Although their primary cell cultures are considered a good experimental model with no genetic changes, the finite life span may limit some experimental designs. The immortalization process increases cell life span but may cause genetic changes and chromosomal instability, resulting in direct effects on physiological cell responses. In this way, we aimed to investigate the global gene expression of hPLFs after the immortalization process by the ectopic expression of the catalytic subunit of the enzyme telomerase reverse transcriptase (hTERT) through transcriptome analysis. The embryonic origin of the primary culture of hPLF cells and immortalized hPLF-hTERT was also tested by vimentin staining, hTERT synthesis evaluated by indirect immunocytochemistry, analysis of cell proliferation, and morphology. The results indicated that hPLFs and hPLF-hTERT were positive for vimentin. On the 20th cell passage, hPLFs were in senescence, while hPLF-hTERT maintained their proliferation and morphology characteristics. At the same passage, hPLF-hTERT presented a significant increase in hTERT synthesis, but transcriptome did not reveal overexpression of the hTERT gene. Fifty-eight genes had their expression altered (11 upregulated and 47 downregulated) with the absence of changes in the key genes related to these cell types and in the main cancer-associated genes. In addition, the increase in hTERT protein expression without the overexpression of its gene indicates posttranscriptional level regulation. Successful immortalization of hPLFs through the ectopic expression of hTERT encourages further studies to design experimental protocols to investigate clinical questions from a translational perspective.</p>
</abstract>
<kwd-group>
<kwd>S100A7</kwd>
<kwd>cell culture</kwd>
<kwd>periodontal fibroblast</kwd>
<kwd>immortalization</kwd>
<kwd>hTERT</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Human periodontal ligament fibroblast (hPLF) cells play an important role in oral cavity homeostasis, being an important contributor to the regeneration of the periodontium through the production and secretion of extracellular matrix components, especially collagen fibers, that link the alveolar bone to the cementum covering the tooth root (<xref ref-type="bibr" rid="B27">Marchesan et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B31">Smith et&#x20;al., 2019</xref>). hPLF cells also participate actively in the immune and inflammatory events in periodontal diseases, producing cytokines and chemokines (<xref ref-type="bibr" rid="B32">Takashiba et&#x20;al., 2003</xref>; <xref ref-type="bibr" rid="B27">Marchesan et&#x20;al., 2011</xref>). These cells acquired from fresh periodontal ligament tissue are heterogeneous populations with different self-renewal capacities, wherein their potential for differentiation in a long-term culture can diminish the number of cells. <xref ref-type="bibr" rid="B22">Lallier and Spencer (2007)</xref> indicated that hPLF differentiation in culture was under the complex regulation of several soluble factors that possibly consigned these cells to distinct fates, suggesting that periodontal fibroblast culture is similar to fresh ligament tissue but especially represents the immature form of these&#x20;cells.</p>
<p>
<italic>In vitro</italic> experiments using isolated cells from fresh tissues usually reflect the biochemical responses of the cells <italic>in vivo</italic> but have the important restriction of limited life span and cells become senescent. Primary hPLF cultures demonstrated that senescence significantly impairs the ability toward an osteoblastic differentiation (<xref ref-type="bibr" rid="B21">Konstantonis et&#x20;al., 2013</xref>). On the other hand, the continuous cell lines are easy to use, and have unlimited life span that provides homogeneous and reproducible data, and considered as transformed cells. This process generates either naturally or by genetic transformation named cell line immortalization.</p>
<p>There are several ways to acquire transformed cells but these mostly involve viruses such as Epstein&#x2013;Barr virus (EBV), adenovirus, human papillomavirus (HPV), and simian virus 40 large T (SV40). SV40 protocol is one of the most used immortalizing agents, but their methodology is restricted by slowing of cellular growth and widespread apoptosis (<xref ref-type="bibr" rid="B3">Bryan and Reddel, 1994</xref>; <xref ref-type="bibr" rid="B26">Lustig, 1999</xref>). Evidence shows that the timing of cellular senescence in human cells is directly related to the length of telomeres and repetitive TTAGGG sequences at the ends of each chromosome (<xref ref-type="bibr" rid="B7">Cong et&#x20;al., 2002</xref>), and most somatic cells undergo a progressive loss of their telomeric DNA in each division because of the end replication problem and other cellular/molecular events (<xref ref-type="bibr" rid="B9">Counter et&#x20;al., 1998</xref>). In this perspective, the ectopic expression of the catalytic subunit of telomerase reverse transcriptase enzyme (hTERT) can successfully reverse this process.</p>
<p>Although previous studies have reported successful immortalization of the periodontal fibroblast cells by hTERT expression or the SV40 protocol (12&#x2013;14), they focused on maintenance (or not) of the genes specifically related to the key functions of these types of cells. Thus, our main goal was to examine the overall gene expression profile of the immortalized human periodontal ligament fibroblast (hPLF-hTERT). We conducted the immortalization process in hPLF primary cells using the hTERT expression protocol, followed by confirmation of the immortalization process through indirect immunofluorescence of hTERT synthesis, cell proliferation, and cell morphology, and finally, we performed the gene expression profile through transcriptome analysis.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>Materials and Methods</title>
<sec id="s2-1">
<title>Ethics and Cell Line Immortalization</title>
<p>Primary hPLFs were obtained from human patients under approval of the Human Research Ethics Committee (Comit&#xea; de &#xe9;tica em pesquisa em seres humanos CEP-ICS/UFPA, CAEE number 0121.0.073.000-11). hPLFs from the primary culture were grown in two culture flasks, denominated F1 and F2, and kept in an incubator at 37&#xb0;C in a humid atmosphere and 5% CO<sub>2</sub>. Concomitantly, in the F2 flask, only the cell culture medium was renewed. Hexadimethrine bromide (polybrene, Sigma-Aldrich<sup>&#xae;</sup>, St. Louis, MO, United&#x20;States) was added to both flasks, and the immortalized strain was selected with antibiotic G428 (Sigma-Aldrich<sup>&#xae;</sup>). After 7&#xa0;days, the selection was completed. All experimental steps are described in <xref ref-type="fig" rid="F1">Figure&#x20;1</xref>.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Methodological scheme of the experimental design. The primary culture of human periodontal ligament fibroblasts (hPLF) was immortalized by the telomerase reverse transcriptase enzyme (hTERT) protocol, and then the transcriptome analysis through microarray was performed using bioinformatics tools.</p>
</caption>
<graphic xlink:href="fmolb-08-679548-g001.tif"/>
</fig>
</sec>
<sec id="s2-2">
<title>Maintenance of the Cell Culture</title>
<p>Both original hPLFs and immortalized hPLF-hTERT were cultured in Dulbecco&#x2019;s modified Eagle&#x2019;s medium (DMEM) and Ham&#x2019;s F-12 nutrient medium (1:1), supplemented with 10% fetal bovine serum (FBS), 100&#xa0;U/ml penicillin, and 100&#xa0;&#x3bc;g/ml streptomycin, incubated at 37&#xb0;C in 5% CO<sub>2</sub> (<xref ref-type="bibr" rid="B28">Nogueira et&#x20;al., 2019</xref>). The medium was changed every 48&#xa0;h. When cells became fully confluent, they were passaged using 0.25% trypsin solutions and seeded in new flasks. About 20 passages were used in our experiments.</p>
</sec>
<sec id="s2-3">
<title>Indirect Immunofluorescence</title>
<sec id="s2-3-1">
<title>Cell Characterization</title>
<p>Primary cell culture (hPLF) and immortalized (hPLF-hTERT) cells were characterized using vimentin label (<xref ref-type="bibr" rid="B8">Costa et&#x20;al., 2020</xref>). Cells were cultured on glass coverslips in 24-well plates, and then they were fixed in 2% paraformaldehyde for 10&#xa0;min with 0.5% Triton x-100 solution (Sigma-Aldrich<sup>&#xae;</sup>; 15&#xa0;min). Following that, cells were washed with PBS, incubated with 1% PBS/FBS (BSA, bovine serum albumin, Sigma-Aldrich<sup>&#xae;</sup>) for 30&#xa0;min, and then incubated with the primary monoclonal antibodies diluted in 1% PBS/BSA for at least 12&#xa0;h and at most 18&#xa0;h in a humid chamber at 4&#xb0;C. The primary antibody used was anti-vimentin, mouse monoclonal antibodies (1:100; Diagnostic BioSystems, Pleasanton, CA, United&#x20;States). To detect primary antibodies, secondary antibodies conjugated to Alexa Fluor 488 or 588 (Invitrogen, Carlsbad, CA, United&#x20;States) were used and Hoechst 33258 (1: 2000, Sigma, St. Louis, MO, United&#x20;States) to label the nuclei. The secondary antibody and Hoechst were diluted in PBS/BSA and incubated for 1&#xa0;h in a humid and dark chamber at room temperature. After that, the coverslip was washed for 5&#xa0;min with PBS solution and twice in distilled water before being mounted on glass slides, using ProLong Gold antifade reagent (Invitrogen, Carlsbad, CA, United&#x20;States). Afterward, the slides were examined under a fluorescence microscope (Axio Scope A1, Zeiss) equipped with a digital camera (AxioCam MRc, Zeiss). As a negative control, the same protocol was performed without incubation of the primary antibody.</p>
</sec>
<sec id="s2-3-2">
<title>Telomerase Reverse Transcriptase Enzyme Synthesis</title>
<p>The same protocol mentioned before was applied to evaluate the hTERT protein expression in the primary cell culture (hPLF) and immortalized cells (hPLF-hTERT). However, the cells were incubated with primary monoclonal antibody anti-TERT (1:50) diluted in 1% PBS/BSA for 12&#x2013;18&#xa0;h in a humid chamber at 4&#xb0;C.</p>
</sec>
</sec>
<sec id="s2-4">
<title>Gene Expression</title>
<sec id="s2-4-1">
<title>RNA Extraction</title>
<p>hPLF and hPLF-hTERT from 20a passage were maintained in cell culture conditions until they acquired 80% confluency. Following that, cells were removed using 0.25% trypsin solution and centrifuged (1,800&#xa0;rpm for 5&#xa0;min). The pellets formed in both flasks were used to extract the RNA using the SV total RNA isolation system kit from Promega<sup>&#xae;</sup>. The samples were homogenized in RNA lysis buffer containing beta-mercaptoethanol, followed by transfer to a fresh tube containing RNA dilution buffer. Samples were centrifuged and transferred to a new tube containing 95% ethanol solution. Following that, samples were transferred to a spin column, and three centrifugation steps of 1&#xa0;min/14&#xa0;<italic>g</italic> were performed. The first step used RNA wash solution, then the DNAse Stop solution, and, finally, an RNA wash solution. The RNA extracted was eluted into an elution tube using 15&#xa0;&#xb5;l of nuclease-free water. RNA quantification was performed using TapeStation 4200 (Agilent Technologies), and the A260/280 ratio analyzed using Nanodrop ND-1000 UV-Vis spectrophotometer, version 3.2.1 (<xref ref-type="sec" rid="s11">Supplementary Material</xref>). The purified RNA was stored at &#x2212;80&#xb0;C for posterior gene expression&#x20;assay.</p>
</sec>
<sec id="s2-4-2">
<title>Gene Expression Analysis&#x2014;Microarray</title>
<p>The microarray analysis was performed using &#x201c;one-color microarray&#x2013;based gene expression analysis&#x201d; (Agilent technologies, EUA). The RNA obtained from hPLF and hPLF-hTERT extraction was used to synthesize the first cDNA, which occurs through reverse transcription assisted by T7 RNA polymerase. The cRNA was transcripted from the second cDNA strand, and 3-cyanine was labeled into the cRNA, followed by RNA purification. The RNA purification was performed using the RNeasy Mini Spin Kit. The cRNA was quantified for spectrophotometry, where the A260/280 ratio and concentration were also analyzed (Nanodrop ND-1000 UV-Vis, version 3.2.1). In order to perform the hybridization, the fragmentation mix was added to the RNA from both hPLF and hPLF-hTERT samples and incubated at 60&#xb0;C for 30&#xa0;min. Following that, to each sample 25&#xa0;&#xb5;l of 2x-RPM hybridization buffer was added at 4&#xb0;C. Then 40&#xa0;&#xb5;l of each sample was added to the hybridization lamina and left in the hybridization camera for 17&#xa0;h at 10&#xa0;rpm and 65&#xb0;C. After that, the samples were read in a microarray scanner from Agilent (G4900DA) and the images obtained from the software Feature Extraction v10.10 for data analysis through bioinformatics.</p>
</sec>
</sec>
<sec id="s2-5">
<title>Bioinformatic Analysis</title>
<p>Quality control, quantile normalization, and batch effect removal were performed using the limma package. Differentially expressed genes were identified based on an absolute log2-fold change level &#x3e;1 and the <italic>p</italic>-value adjusted by FDR &#x3c;0.05. Overrepresentation analysis for differently expressed genes of gene ontology (GO) terms or KEGG pathways was also done with the limma package. Overrepresented <italic>p</italic>-values were adjusted by the Bonferroni method, and only adjusted <italic>p</italic>-values &#x3c;0.05 were considered.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec id="s3-1">
<title>Human Periodontal Ligament Fibroblasts <italic>Vs.</italic> Immortalized Human Periodontal Ligament Fibroblasts</title>
<p>First, the mesenchymal origin of the cell lines hPLF and hPLF-hTERT analyzed through indirect immunofluorescence was found to be positive for vimentin in both of them (<xref ref-type="fig" rid="F2">Figures 2A&#x2013;F</xref>). Following that, to initiate the evaluation of the immortalization performance, both cell lines were tested through antibiotic selection. As a result, phase-contrast photomicrography exhibited cell death in hPLF during the selection (<xref ref-type="fig" rid="F3">Figure&#x20;3A</xref>), while hPLF-hTERT cells maintained proliferation and cell morphology (<xref ref-type="fig" rid="F3">Figure&#x20;3B</xref>). Last, the performance of indirect immunofluorescence to evaluate the expression of hTERT after immortalization demonstrated weak hTERT staining in hPLF, while hPLF-hTERT showed an expressive presence of the protein. In terms of percentage, the fluorescence of phalloidin, hTERT, and nucleus represents 73.61, 17.48, and 8.89%, respectively, while in the immortalized hPLF-hTERT cells, these percentages were 43.89, 47.0, and 8.98%, respectively (<xref ref-type="fig" rid="F4">Figure&#x20;4</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Vimentin expression present as filamentous network in hPLF <bold>(A, C)</bold> and hPLF-hTERT <bold>(D, F)</bold> demonstrating the mesenchymal origin in both cell lines. Hoechst 33258 was used for nuclear counterstaining <bold>(B, C, E, F)</bold>. Scale bar: 20&#xa0;&#xb5;m.</p>
</caption>
<graphic xlink:href="fmolb-08-679548-g002.tif"/>
</fig>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Phase-contrast microscopy displays hPLF <bold>(A)</bold> and immortalized human periodontal fibroblasts (hPLF-hTERT) <bold>(B)</bold>, both cell lines with spindle-shaped phenotype. Scale bar: 100&#xa0;&#xb5;m.</p>
</caption>
<graphic xlink:href="fmolb-08-679548-g003.tif"/>
</fig>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Expression of hTERT was weak in hPFL <bold>(B, D)</bold> and strong in hPLF-hTERT <bold>(F, H)</bold> cell lines, respectively, and observed as an intracellular dot-like staining. Actin staining (Alexa Fluor 568 phalloidin) reveals the cortical cytoskeleton <bold>(A, D, E, H)</bold>. Hoechst 33258 was used for nuclear counterstaining <bold>(C, D, G, H)</bold>. Scale bar: 20&#xa0;&#xb5;m.</p>
</caption>
<graphic xlink:href="fmolb-08-679548-g004.tif"/>
</fig>
</sec>
<sec id="s3-2">
<title>Immortalization Process Modulated the Expression of a Few Genes</title>
<p>Fifty-eight genes were found to be differentially expressed, in which 11 were upregulated and 47 downregulated (<xref ref-type="fig" rid="F5">Figure&#x20;5</xref>; <xref ref-type="table" rid="T1">Table&#x20;1</xref>). In terms of percentage, the altered genes after the immortalization process represent 0.22% of the total 26,000 genes analyzed through the microarray. As observed in the heatmap (<xref ref-type="fig" rid="F6">Figure&#x20;6</xref>), along with the 58 genes, there was a pattern of gene expression modulation among each group of cells, represented by the proximity of dendrograms.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Volcano plot representing the global profile of gene expression of hPLF cells after the immortalization procedure. Blue dots represent downregulated genes and red dots represent upregulated genes. Data were expressed as log2FC &#x3e; 1 or &#x3c; &#x2212;1 and analyzed by Student&#x2019;s <italic>t</italic>-test, adopting adj. <italic>p</italic>&#x20;&#x3c; 0.05 (<italic>n</italic>&#x20;&#x3d; 3/each group).</p>
</caption>
<graphic xlink:href="fmolb-08-679548-g005.tif"/>
</fig>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Top ten genes upregulated and downregulated showing altered expression in hPLF-hTERT compared to the primary cell culture of hPLF. Gene fold regulation and <italic>p</italic>-value are reported for each&#x20;gene.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Gene symbol</th>
<th align="center">Gene description</th>
<th align="center">logFC (x10<sup>14</sup>)</th>
<th align="center">Adjusted <italic>p</italic>-value</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">FOSL1</td>
<td align="left">FOS like 1, AP-1 transcription factor subunit</td>
<td align="char" char=".">1.75</td>
<td align="char" char=".">0.049</td>
</tr>
<tr>
<td align="left">CXCL1</td>
<td align="left">C-X-C motif chemokine ligand 1</td>
<td align="char" char=".">1.70</td>
<td align="char" char=".">0.040</td>
</tr>
<tr>
<td align="left">S100A7</td>
<td align="left">S100&#x20;calcium-binding protein A7</td>
<td align="char" char=".">1.55</td>
<td align="char" char=".">0.040</td>
</tr>
<tr>
<td align="left">DEFB4A</td>
<td align="left">Defensin beta 4A</td>
<td align="char" char=".">1.37</td>
<td align="char" char=".">0.040</td>
</tr>
<tr>
<td align="left">PDZK1IP1</td>
<td align="left">PDZK1 interacting protein 1</td>
<td align="char" char=".">1.26</td>
<td align="char" char=".">0.040</td>
</tr>
<tr>
<td align="left">CXCL2</td>
<td align="left">C-X-C motif chemokine ligand 2</td>
<td align="char" char=".">1.11</td>
<td align="char" char=".">0.040</td>
</tr>
<tr>
<td align="left">SOX15</td>
<td align="left">SRY-box transcription factor 15</td>
<td align="char" char=".">1.08</td>
<td align="char" char=".">0.046</td>
</tr>
<tr>
<td align="left">SLC27A4</td>
<td align="left">Solute carrier family 27 member 4</td>
<td align="char" char=".">1.07</td>
<td align="char" char=".">0.040</td>
</tr>
<tr>
<td align="left">HS3ST2</td>
<td align="left">Heparan sulfate-glucosamine 3-sulfotransferase 2</td>
<td align="char" char=".">1.02</td>
<td align="char" char=".">0.040</td>
</tr>
<tr>
<td align="left">CXCL6</td>
<td align="left">C-X-C motif chemokine ligand 6</td>
<td align="char" char=".">1.29</td>
<td align="char" char=".">0.040</td>
</tr>
<tr>
<td align="left">XAGE2B</td>
<td align="left">X antigen family member 2</td>
<td align="char" char=".">&#x2212;1.28</td>
<td align="char" char=".">0.040</td>
</tr>
<tr>
<td align="left">PNPLA7</td>
<td align="left">Patatin-like phospholipase domain&#x2013;containing 7</td>
<td align="char" char=".">&#x2212;1.31</td>
<td align="char" char=".">0.040</td>
</tr>
<tr>
<td align="left">LOC100505701</td>
<td align="left">Uncharacterized</td>
<td align="char" char=".">&#x2212;1.33</td>
<td align="char" char=".">0.048</td>
</tr>
<tr>
<td align="left">BTBD16</td>
<td align="left">BTB domain&#x2013;containing 16</td>
<td align="char" char=".">&#x2212;1.41</td>
<td align="char" char=".">0.049</td>
</tr>
<tr>
<td align="left">ZNF862</td>
<td align="left">Zinc finger protein 862</td>
<td align="char" char=".">&#x2212;1.42</td>
<td align="char" char=".">0.017</td>
</tr>
<tr>
<td align="left">CECR5-AS1</td>
<td align="left">HDHD5 antisense RNA 1</td>
<td align="char" char=".">&#x2212;1.51</td>
<td align="char" char=".">0.040</td>
</tr>
<tr>
<td align="left">IGDCC3</td>
<td align="left">Immunoglobulin superfamily DCC subclass member 3</td>
<td align="char" char=".">&#x2212;1.63</td>
<td align="char" char=".">0.040</td>
</tr>
<tr>
<td align="left">C17orf108</td>
<td align="left">LYR motif&#x2013;containing 9</td>
<td align="char" char=".">&#x2212;1.70</td>
<td align="char" char=".">0.040</td>
</tr>
<tr>
<td align="left">SSPN</td>
<td align="left">Sarcospan</td>
<td align="char" char=".">&#x2212;1.74</td>
<td align="char" char=".">0.046</td>
</tr>
<tr>
<td align="left">GABRP</td>
<td align="left">Gamma-aminobutyric acid type a receptor subunit pi</td>
<td align="char" char=".">&#x2212;1.92</td>
<td align="char" char=".">0.0447</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Heatmap of differentially expressed genes in hPLF after the immortalization process (control vs. hTERT). The dendrograms represent the hierarchical cluster relationship between genes (left side) and among samples (upper), based on Pearson&#x2019;s correlation; log2FC &#x3e; 1 or &#x3c; &#x2212;1. log2-fold change &#x3e;1.5 or &#x3c;&#x2212;1.5; adj.; cut-off adj. <italic>p</italic>-value: &#x3c;0.05.</p>
</caption>
<graphic xlink:href="fmolb-08-679548-g006.tif"/>
</fig>
<p>Modulated genes are involved in 20 different pathways, as observed in <xref ref-type="fig" rid="F7">Figure&#x20;7</xref>, including TNF signaling pathway (four genes), NOD-like receptor signaling pathway (four genes), NF-kappa B signaling pathway (three genes), amebiasis (three genes), human T-cell leukemia virus 1 infection (three genes), cytokine&#x2013;cytokine receptor interaction, and 15 other pathways.</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>Graph representing KEGG pathways associated with the differentially expressed genes in hPLF after immortalization processes and their respective number of genes found in the transcriptome analysis.</p>
</caption>
<graphic xlink:href="fmolb-08-679548-g007.tif"/>
</fig>
</sec>
<sec id="s3-3">
<title>Analysis of Gene Ontology of the Transcriptome</title>
<p>The genes with significantly altered expression are involved in 447 different biological processes. Among them, we highlighted ten processes with the highest number of involved genes: a multicellular organismal process (17 genes), extracellular region (17 genes), response to external stimulus (14 genes), extracellular space (13 genes), extracellular region part (13 genes), response to stress (13 genes), locomotion (12 genes), defense response (11 genes), movement of cell or subcellular component (11 genes), and cellular response to chemical stimulus (11 genes) (<xref ref-type="fig" rid="F8">Figure&#x20;8</xref>). Besides that, changes in biological processes related specifically to the immortalization process, such as cell migration, cell motility, and cell adhesion, were observed.</p>
<fig id="F8" position="float">
<label>FIGURE 8</label>
<caption>
<p>Graph representing the top-ranking biological processes of differentially expressed genes in hPLF after immortalization processes and their respective number of genes found by transcriptome analysis. Biological processes based on gene ontology annotation, adopting <italic>p</italic>&#x20;&#x3c; 0.05.</p>
</caption>
<graphic xlink:href="fmolb-08-679548-g008.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>In this study, immortalization of the primary cell culture of the periodontal ligament through the hTERT technique helped reach the goal of increasing the life span of cells through the maintenance of proliferation and morphology. Surprisingly, the process was posttranscriptionally controlled by the significant increase of hTERT synthesis with no change in hTERT gene expression. The identification of 58 changes in the gene profile after hPLF cell immortalization is considered a low number compared with changes in gene expression of fresh tissue and hPLF after culturing (<xref ref-type="bibr" rid="B22">Lallier and Spencer, 2007</xref>). In the study published by <xref ref-type="bibr" rid="B22">Lallier and Spencer (2007)</xref>, although these populations were considered similar, they differed in their expression of roughly 3,240 genes (6% of total analyzed). Thus, considering only the gene numbers, the hTERT immortalization protocol performed by us did not generate profound gene modifications ,which is in agreement with the observations of low phenotypic and karyotypic changes of this protocol compared with a virus protocol, such as SV40 (<xref ref-type="bibr" rid="B35">Wang et&#x20;al., 2019</xref>).</p>
<p>The first indication of a successful immortalization process is hPLF-hTERT cultivation over the 20th passage. The primary cell culture of hPLF showed characteristics of senescence (<xref ref-type="bibr" rid="B6">Chen et&#x20;al., 2000</xref>) at the 20th passage, with a large and flattened morphology and decreased rate of proliferation, while the hPLF-hTERT maintained their fusiform shape and short cytoplasmic extensions, preserving their proliferation and normal morphology.</p>
<p>The second indicator of a functional immortalization process occurred from labeling the hTERT expression using indirect immunocytochemistry. The immortalized cells, hPLF-hTERT, exhibited an expressive increase in telomerase activity/expression, which is considered one of the major biochemical steps to increase cell culture life span, but not sufficient <italic>per se</italic> for oncogenic transformations (<xref ref-type="bibr" rid="B13">Franzese et&#x20;al., 2002</xref>), while the primary cell culture of hPLF demonstrated a weak labeling expression of the catalytic subunit hTERT, consistent with most human cells that are telomerase negative (<xref ref-type="bibr" rid="B36">Weinrich et&#x20;al., 1997</xref>).</p>
<p>The hTERT telomerase expression was estimated to occur transcriptionally in immortalized hPLF-hTERT cells, but upregulation of the hTERT gene did not occur. As observed for other cell types such as lymphocytes (<xref ref-type="bibr" rid="B24">Liu et&#x20;al., 2001</xref>) and HTLV-I cells (<xref ref-type="bibr" rid="B2">Bellon and Nicot, 2015</xref>), the transcriptome result leads us to believe that the hTERT regulation was carried out in a posttranscriptional manner. According to the literature, nuclear factor-kB (NF-kB) is the main key in the regulation of telomerase activity through the modulation of nuclear translocation that occurs mainly over the induction of the tumor necrosis factor (TNF) (<xref ref-type="bibr" rid="B1">Akiyama et&#x20;al., 2003</xref>), which is one of the most potent physiological inducers of the nuclear transcription factor NF-kB (<xref ref-type="bibr" rid="B25">Liu et&#x20;al., 2017</xref>). In our study, upregulation of TNF in immortalized hPLF-hTERT cells, along with the observed changes in the NF-k&#x3b2; pathway, highly indicates the posttranscriptional process.</p>
<p>In addition to this mechanism, an important marker of hTERT dysfunction was upregulated in hPLF-hTERT, the S100A7 gene. The occurrence of upregulated S100A7 is a direct consequence of telomere dysfunction in human keratinocytes independently of cell cycle regulators (<xref ref-type="bibr" rid="B11">de Castro et&#x20;al., 2014</xref>). Besides that, the overexpression of S100A7 is associated with a chemokine and cytokine action (<xref ref-type="bibr" rid="B17">Jinquan et&#x20;al., 1996</xref>; <xref ref-type="bibr" rid="B10">D&#x2019;Amico et&#x20;al., 2016</xref>), involved in an inflammatory response and latter stimuli to odontoclast differentiation (<xref ref-type="bibr" rid="B4">Charoenpong et&#x20;al., 2019</xref>).</p>
<p>Although we did not observe an overexpression of the hTERT gene, there are markers and pathways that explain the observed successful cell immortalization of the hPLF primary cell culture. Based on gene ontology results, important characteristics of the overexpression of hTERT in other cell types, such as promotion of cell adhesion, motility, and migration (<xref ref-type="bibr" rid="B5">Chen et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B23">Liu et&#x20;al., 2016</xref>), were also observed in the hPLF-hTERT. Altered genes were related to cell motility (GO: 0048870&#x20;&#x3d; 10 genes) and regulation of cell motility (GO: 2000145&#x20;&#x3d; 5 genes), cell migration (GO: 0016477&#x20;&#x3d; 10 genes), positive regulation of heterotypic cell&#x2013;cell adhesion (GO: 0034116&#x20;&#x3d; 1 gene), regulation of cell&#x2013;cell adhesion (GO: 0022407&#x20;&#x3d; 3 genes), and positive regulation of cell adhesion (GO: 0045785&#x20;&#x3d; 3 genes).</p>
<p>Taking into account the pathways designated as altered by KEGG (Kyoto Encyclopedia of Genes and Genomes) in hPLF-hTERT, most parts of them are exclusively linked to pro-inflammatory response, innate immune response, and metabolism responses. The fibroblasts of the periodontal ligament participate in immune and inflammatory events in periodontal diseases, with producing cytokines and chemokines as one of their main functions (<xref ref-type="bibr" rid="B32">Takashiba et&#x20;al., 2003</xref>), besides being responsible for structural composition and secretion of extracellular components (e.g., collagen and glycosaminoglycans) and tissue repair (<xref ref-type="bibr" rid="B27">Marchesan et&#x20;al., 2011</xref>). However, the immortalization process did not cause direct changes in genes related to mineralization (osteopontin, alkaline phosphatase, osteomodulin, and collagen type I, II, and V), cell motility (collagen type I and fibronectin), and cell migration (collagen type 1) and proliferation, thus implicating its importance in the maintenance of hPLF characteristics and main functions. These observations agree with previous studies where the immortalization process (by hTERT expression or SV40 protocol) induced the increase in life span without cells losing their ability to repair and regenerate dental and periodontal tissues (<xref ref-type="bibr" rid="B18">Kamata et&#x20;al., 2004</xref>; <xref ref-type="bibr" rid="B14">Fujii et&#x20;al., 2006</xref>; <xref ref-type="bibr" rid="B33">Tomokiyo et&#x20;al., 2008</xref>).</p>
<p>One of the altered pathways in hPLF-hTERT with the highest number of genes overexpressed was the cytokinine&#x2013;cytokine receptor pathway. Cytokines represent a diverse group of molecules that bind to receptors on target cells and activate a cascade of intercellular signals. One of the families that belong to this pathway is the CXCL family; three of their genes were upregulated in our study (CXCL1, CXCL4, and CXCL6). In the oral cavity, the role of cytokines in the progression of periodontitis is particularly important as they act as the first response against pathogens and connect tissue cells with lymphocytes and accessory cell populations (<xref ref-type="bibr" rid="B16">Graves, 2008</xref>).</p>
<p>The most overexpressed gene in hPLF-hTERT was FOSL1 or AP-1 which is linked by different stimuli, such as inflammatory cytokines, stress inducers, or pathogens, resulting in innate and adaptive immunity (<xref ref-type="bibr" rid="B15">Gazon et&#x20;al., 2017</xref>). AP-1 is also involved in various cellular events, including differentiation, proliferation, survival, and apoptosis. The downregulation causes inhibition of growth cell lines and tumor both <italic>in vivo</italic> and <italic>in&#x20;vitro</italic> (<xref ref-type="bibr" rid="B12">Eckert et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B19">Kharman-Biz et&#x20;al., 2013</xref>). In hPLF-hTERT, this gene is related to different pathways pointed out by KEGG, such as epithelial cell signaling in <italic>Helicobacter pylori</italic> infection, pertussis, hepatitis B, TNF signaling pathway, and NOD-like receptor signaling pathway.</p>
<p>Another important upregulated gene in hPLF-hTERT was beta-defensin 2 (DEFB4A). Two of several different pathways of gene activation were observed in the immortalized cell line: NOD-2&#x2013;dependent NF-k&#x3b2; activation (<xref ref-type="bibr" rid="B35">Wang et&#x20;al., 2019</xref>). Crucial in the innate immune response (<xref ref-type="bibr" rid="B30">Saxena and Yeretssian, 2014</xref>), the NOD-like receptors (NLRs) in signaling pathways are transmembrane receptors that show various functions such as inflammasome formation, signaling transduction, transcription activation, and autophagy (<xref ref-type="bibr" rid="B20">Kim et&#x20;al., 2016</xref>). The increase in beta-defensin 2 protein is considered pro-inflammatory and innate immune response, which has marked antimicrobial properties (<xref ref-type="bibr" rid="B29">Roesner et&#x20;al., 2017</xref>).</p>
</sec>
<sec sec-type="conclusion" id="s5">
<title>Conclusion</title>
<p>Taking together, the immortalization process using ectopic expression of hTERT in the hPLF primary cell culture resulted in an increase in life span of cells with the maintenance of their phenotypic characteristics. Although some studies suggest the requirement of secondary inactivation of regulator pathways, such as p16 and pRB, for the cell immortalization process (<xref ref-type="bibr" rid="B9">Counter et&#x20;al., 1998</xref>; <xref ref-type="bibr" rid="B34">Wall et&#x20;al., 2016</xref>), our study is in agreement with others and suggests the reconstitution of telomerase by hTERT activation in a posttranscriptional manner that is sufficient to immortalize primary human cells. These results indicate in a pioneering way the changes that occurred in the general profile of hPLF gene expression after the immortalization process. In the future, hPLF-hTERT should be evaluated regarding the maintenance of its physiological responses to periodontal ligament fibroblasts, such as collagen production, extracellular matrix, and inflammatory responses. Thus, new studies need to be developed in order to create experimental protocols that investigate clinical issues from a translational perspective.</p>
</sec>
</body>
<back>
<sec id="s6">
<title>Data Availability Statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="sec" rid="s11">Supplementary Material</xref>. Further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s7">
<title>Ethics Statement</title>
<p>The studies involving human participants were reviewed and approved by the Human Research Ethics Committee (Comit&#xea; de &#xe9;tica em pesquisa em seres humanos CEP-ICS/UFPA, CAEE number 0121.0.073.000-11). The patients/participants provided their written informed consent to participate in this study.</p>
</sec>
<sec id="s8">
<title>Author Contributions</title>
<p>LN, EO, and RL designed the study. LN, CV, GM, JP, and MK performed analysis of results and manuscript elaboration. LB, GG, JP, EO, and RL reviewed and edited the manuscript. LN, EO, and RL performed analysis of results, manuscript elaboration, and final text approval for submission.</p>
</sec>
<sec id="s9">
<title>Funding</title>
<p>This study was partially supported by a grant provided by CNPq (Brazilian National Council for Scientific and Technological Development, 435093/2018-5) and CAPES/PROCAD - Higher Education Improvement Coordination (23038.005350/2018-78; Finance Code 001). The APC was funded by Pr&#xf3;-Reitoria de Pesquisa e P&#xf3;s-gradua&#xe7;&#xe3;o from the Federal University of Par&#xe1; (PROPESP-UFPA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p>
</sec>
<sec sec-type="COI-statement" id="s10">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<ack>
<p>The authors are grateful to the Brazilian National Council for Scientific and Technological Development (CNPq) and Programa Nacional de Coopera&#xe7;&#xe3;o Acad&#xea;mica na Amaz&#xf4;nia&#x2014;PROCAD/Amaz&#xf4;nia da Coordena&#xe7;&#xe3;o de Aperfei&#xe7;oamento de Pessoal de N&#xed;vel Superior (CAPES).</p>
</ack>
<sec id="s11">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fmolb.2021.679548/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fmolb.2021.679548/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.docx" id="SM1" mimetype="application/docx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akiyama</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hideshima</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hayashi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tai</surname>
<given-names>Y. T.</given-names>
</name>
<name>
<surname>Mitsiades</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>Mitsiades</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2003</year>). <article-title>Nuclear Factor-kappaB P65 Mediates Tumor Necrosis Factor Alpha-Induced Nuclear Translocation of Telomerase Reverse Transcriptase Protein</article-title>. <source>Cancer Res.</source> <volume>63</volume>, <fpage>18</fpage>&#x2013;<lpage>21</lpage>. </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bellon</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nicot</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Multiple Pathways Control the Reactivation of Telomerase in HTLV-I-Associated Leukemia</article-title>. <source>Int. J.&#x20;Cancer Oncol.</source> <volume>2</volume> (<issue>2</issue>), <fpage>215</fpage>. <pub-id pub-id-type="doi">10.15436/2377-0902.15.017</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bryan</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Redder</surname>
<given-names>R. R.</given-names>
</name>
</person-group> (<year>1994</year>). <article-title>SV40-lnduced Immortalization of Human Cells</article-title>. <source>Crit. Rev. Oncog</source> <volume>5</volume>, <fpage>331</fpage>&#x2013;<lpage>357</lpage>. <pub-id pub-id-type="doi">10.1615/critrevoncog.v5.i4.10</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Charoenpong</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Osathanon</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Pavasant</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Limjeerajarus</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Keawprachum</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Limjeerajarus</surname>
<given-names>C. N.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Mechanical Stress Induced S100A7 Expression in Human Dental Pulp Cells to Augment Osteoclast Differentiation</article-title>. <source>Oral Dis.</source> <volume>25</volume>, <fpage>812</fpage>&#x2013;<lpage>821</lpage>. <pub-id pub-id-type="doi">10.1111/odi.13033</pub-id> </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>P.-C.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>J.-R.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W.-X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W.-Z.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>Z.-Q. -Q.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Overexpression of Human Telomerase Reverse Transcriptase Promotes the Motility and Invasiveness of HepG2 Cells <italic>In Vitro</italic>
</article-title>. <source>Oncol. Rep.</source> <volume>30</volume>, <fpage>1157</fpage>&#x2013;<lpage>1164</lpage>. <pub-id pub-id-type="doi">10.3892/or.2013.2563</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Q. M.</given-names>
</name>
<name>
<surname>Tu</surname>
<given-names>V. C.</given-names>
</name>
<name>
<surname>Catania</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Burton</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Toussaint</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Dilley</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Involvement of Rb Family Proteins, Focal Adhesion Proteins and Protein Synthesis in Senescent Morphogenesis Induced by Hydrogen Peroxide</article-title>. <source>J.&#x20;Cell. Sci.</source> <volume>113</volume> (<issue>Pt 22</issue>), <fpage>4087</fpage>&#x2013;<lpage>4097</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.113.22.4087</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cong</surname>
<given-names>Y.-S.</given-names>
</name>
<name>
<surname>Wright</surname>
<given-names>W. E.</given-names>
</name>
<name>
<surname>Shay</surname>
<given-names>J.&#x20;W.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Human Telomerase and its Regulation</article-title>. <source>Mmbr</source> <volume>66</volume>, <fpage>407</fpage>&#x2013;<lpage>425</lpage>. <pub-id pub-id-type="doi">10.1128/mmbr.66.3.407-425.2002</pub-id> </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Costa</surname>
<given-names>F. P. d.</given-names>
</name>
<name>
<surname>Puty</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Nogueira</surname>
<given-names>L. S.</given-names>
</name>
<name>
<surname>Mitre</surname>
<given-names>G. P.</given-names>
</name>
<name>
<surname>Santos</surname>
<given-names>S. M. d.</given-names>
</name>
<name>
<surname>Teixeira</surname>
<given-names>B. J.&#x20;B.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Piceatannol Increases Antioxidant Defense and Reduces Cell Death in Human Periodontal Ligament Fibroblast under Oxidative Stress</article-title>. <source>Antioxidants</source> <volume>9</volume>, <fpage>16</fpage>. <pub-id pub-id-type="doi">10.3390/antiox9010016</pub-id> </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Counter</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Meyerson</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Eaton</surname>
<given-names>E. N.</given-names>
</name>
<name>
<surname>Ellisen</surname>
<given-names>L. W.</given-names>
</name>
<name>
<surname>Caddle</surname>
<given-names>S. D.</given-names>
</name>
<name>
<surname>Haber</surname>
<given-names>D. A.</given-names>
</name>
<etal/>
</person-group> (<year>1998</year>). <article-title>Telomerase Activity Is Restored in Human Cells by Ectopic Expression of hTERT (hEST2), the Catalytic Subunit of Telomerase</article-title>. <source>Oncogene</source> <volume>16</volume>, <fpage>1217</fpage>&#x2013;<lpage>1222</lpage>. <pub-id pub-id-type="doi">10.1038/sj.onc.1201882</pub-id> </citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>D&#x2019;Amico</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Skarmoutsou</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Granata</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Trovato</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Rossi</surname>
<given-names>G. A.</given-names>
</name>
<name>
<surname>Mazzarino</surname>
<given-names>M. C.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>S100A7: A rAMPing up AMP Molecule in Psoriasis</article-title>. <source>Cytokine Growth Factor. Rev.</source> <volume>32</volume>, <fpage>97</fpage>&#x2013;<lpage>104</lpage>. <pub-id pub-id-type="doi">10.1016/j.cytogfr.2016.01.002</pub-id> </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Castro</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Minty</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Hattinger</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Wolf</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Parkinson</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>The Secreted Protein S100A7 (Psoriasin) Is Induced by Telomere Dysfunction in Human Keratinocytes Independently of a DNA Damage Response and Cell Cycle Regulators</article-title>. <source>Longevity Healthspan</source> <volume>3</volume>, <fpage>8</fpage>. <pub-id pub-id-type="doi">10.1186/2046-2395-3-8</pub-id> </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eckert</surname>
<given-names>R. L.</given-names>
</name>
<name>
<surname>Adhikary</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Jans</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Crish</surname>
<given-names>J.&#x20;F.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>W.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>AP1 Transcription Factors in Epidermal Differentiation and Skin Cancer</article-title>. <source>J.&#x20;Skin Cancer</source> <volume>2013</volume>, <fpage>1</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1155/2013/537028</pub-id> </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Franzese</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Balestrieri</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Comandini</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Forte</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Macchi</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Bonmassar</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Short Communication: Telomerase Activity of Human Peripheral Blood Mononuclear Cells in the Course of HTLV Type 1 Infection <italic>In Vitro</italic>
</article-title>. <source>AIDS Res. Hum. Retroviruses</source> <volume>18</volume>, <fpage>249</fpage>&#x2013;<lpage>251</lpage>. <pub-id pub-id-type="doi">10.1089/088922202753472810</pub-id> </citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fujii</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Maeda</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wada</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kano</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Akamine</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Establishing and Characterizing Human Periodontal Ligament Fibroblasts Immortalized by SV40T-Antigen and hTERT Gene Transfer</article-title>. <source>Cell Tissue Res</source> <volume>324</volume>, <fpage>117</fpage>&#x2013;<lpage>125</lpage>. <pub-id pub-id-type="doi">10.1007/s00441-005-0101-4</pub-id> </citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gazon</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Barbeau</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Mesnard</surname>
<given-names>J.-M.</given-names>
</name>
<name>
<surname>Peloponese</surname>
<given-names>J.-M.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Hijacking of the AP-1 Signaling Pathway during Development of ATL</article-title>. <source>Front. Microbiol.</source> <volume>8</volume>, <fpage>2686</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2017.02686</pub-id> </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Graves</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Cytokines that Promote Periodontal Tissue Destruction</article-title>. <source>J.&#x20;Periodontol.</source> <volume>79</volume>, <fpage>1585</fpage>&#x2013;<lpage>1591</lpage>. <pub-id pub-id-type="doi">10.1902/jop.2008.080183</pub-id> </citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jinquan</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Vorum</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Larsen</surname>
<given-names>C. G.</given-names>
</name>
<name>
<surname>Madsen</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Rasmussen</surname>
<given-names>H. H.</given-names>
</name>
<name>
<surname>Gesser</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>1996</year>). <article-title>Psoriasin: a Novel Chemotactic Protein</article-title>. <source>J.&#x20;Invest. Dermatol.</source> <volume>107</volume>, <fpage>5</fpage>&#x2013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1111/1523-1747.ep12294284</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kamata</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Fujimoto</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Tomonari</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Taki</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nagayama</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yasumoto</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Immortalization of Human Dental Papilla, Dental Pulp, Periodontal Ligament Cells and Gingival Fibroblasts by Telomerase Reverse Transcriptase</article-title>. <source>J.&#x20;Oral Pathol. Med.</source> <volume>33</volume>, <fpage>417</fpage>&#x2013;<lpage>423</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0714.2004.00228.x</pub-id> </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kharman-Biz</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ghiasvand</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zendehdel</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Dahlman-Wright</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Expression of Activator Protein-1 (AP-1) Family Members in Breast Cancer</article-title>. <source>BMC Cancer</source> <volume>13</volume>, <fpage>441</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2407-13-441</pub-id> </citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>Y. K.</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>J.-S.</given-names>
</name>
<name>
<surname>Nahm</surname>
<given-names>M. H.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>NOD-like Receptors in Infection, Immunity, and Diseases</article-title>. <source>Yonsei Med. J.</source> <volume>57</volume>, <fpage>5</fpage>&#x2013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.3349/ymj.2016.57.1.5</pub-id> </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Konstantonis</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Papadopoulou</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Makou</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Eliades</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Basdra</surname>
<given-names>E. K.</given-names>
</name>
<name>
<surname>Kletsas</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Senescent Human Periodontal Ligament Fibroblasts after Replicative Exhaustion or Ionizing Radiation Have a Decreased Capacity towards Osteoblastic Differentiation</article-title>. <source>Biogerontology</source> <volume>14</volume>, <fpage>741</fpage>&#x2013;<lpage>751</lpage>. <pub-id pub-id-type="doi">10.1007/s10522-013-9449-0</pub-id> </citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lallier</surname>
<given-names>T. E.</given-names>
</name>
<name>
<surname>Spencer</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Use of Microarrays to Find Novel Regulators of Periodontal Ligament Fibroblast Differentiation</article-title>. <source>Cel Tissue Res</source> <volume>327</volume>, <fpage>93</fpage>&#x2013;<lpage>109</lpage>. <pub-id pub-id-type="doi">10.1007/s00441-006-0282-5</pub-id> </citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Ge</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>hTERT Promotes Cell Adhesion and Migration Independent of Telomerase Activity</article-title>. <source>Sci. Rep.</source> <volume>6</volume>, <fpage>22886</fpage>. <pub-id pub-id-type="doi">10.1038/srep22886</pub-id> </citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hodes</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Weng</surname>
<given-names>N.-P.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Cutting Edge: Telomerase Activation in Human T Lymphocytes Does Not Require Increase in Telomerase Reverse Transcriptase (hTERT) Protein but Is Associated with hTERT Phosphorylation and Nuclear Translocation</article-title>. <source>J.&#x20;Immunol.</source> <volume>166</volume>, <fpage>4826</fpage>&#x2013;<lpage>4830</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.166.8.4826</pub-id> </citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Joo</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>S.-C.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>NF-&#x3ba;B Signaling in Inflammation</article-title>. <source>Sig Transduct Target. Ther.</source> <volume>2</volume>, <fpage>17023</fpage>. <pub-id pub-id-type="doi">10.1038/sigtrans.2017.23</pub-id> </citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lustig</surname>
<given-names>A. J.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Crisis Intervention: the Role of Telomerase</article-title>. <source>Proc. Natl. Acad. Sci.</source> <volume>96</volume>, <fpage>3339</fpage>&#x2013;<lpage>3341</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.96.7.3339</pub-id> </citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marchesan</surname>
<given-names>J.&#x20;T.</given-names>
</name>
<name>
<surname>Scanlon</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>Soehren</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Matsuo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kapila</surname>
<given-names>Y. L.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Implications of Cultured Periodontal Ligament Cells for the Clinical and Experimental Setting: a Review</article-title>. <source>Arch. Oral Biol.</source> <volume>56</volume>, <fpage>933</fpage>&#x2013;<lpage>943</lpage>. <pub-id pub-id-type="doi">10.1016/j.archoralbio.2011.03.003</pub-id> </citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nogueira</surname>
<given-names>L. S.</given-names>
</name>
<name>
<surname>Vasconcelos</surname>
<given-names>C. P.</given-names>
</name>
<name>
<surname>Mitre</surname>
<given-names>G. P.</given-names>
</name>
<name>
<surname>da Silva Kataoka</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Lima</surname>
<given-names>M. O.</given-names>
</name>
<name>
<surname>de Oliveira</surname>
<given-names>E. H. C.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Oxidative Damage in Human Periodontal Ligament Fibroblast (hPLF) after Methylmercury Exposure</article-title>. <source>Oxidative Med. Cell Longevity</source> <volume>2019</volume>, <fpage>1</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1155/2019/8470857</pub-id> </citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roesner</surname>
<given-names>L. M.</given-names>
</name>
<name>
<surname>Kienlin</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Begemann</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Dittrich-Breiholz</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Werfel</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Inflammatory Marker Analysis in Psoriatic Skin under Topical Phosphodiesterase 4 Inhibitor Treatment</article-title>. <source>J.&#x20;Allergy Clin. Immunol.</source> <volume>140</volume>, <fpage>1184</fpage>&#x2013;<lpage>1187.e8</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaci.2017.04.026</pub-id> </citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saxena</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yeretssian</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>NOD-like Receptors: Master Regulators of Inflammation and Cancer</article-title>. <source>Front. Immunol.</source> <volume>5</volume>, <fpage>327</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2014.00327</pub-id> </citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>P. C.</given-names>
</name>
<name>
<surname>Mart&#xed;nez</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Mart&#xed;nez</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>McCulloch</surname>
<given-names>C. A.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Role of Fibroblast Populations in Periodontal Wound Healing and Tissue Remodeling</article-title>. <source>Front. Physiol.</source> <volume>10</volume>, <fpage>270</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2019.00270</pub-id> </citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takashiba</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Naruishi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Murayama</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Perspective of Cytokine Regulation for Periodontal Treatment: Fibroblast Biology</article-title>. <source>J.&#x20;Periodontol.</source> <volume>74</volume>, <fpage>103</fpage>&#x2013;<lpage>110</lpage>. <pub-id pub-id-type="doi">10.1902/jop.2003.74.1.103</pub-id> </citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tomokiyo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Maeda</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Fujii</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wada</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Shima</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Akamine</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Development of a Multipotent Clonal Human Periodontal Ligament Cell Line</article-title>. <source>Differentiation</source> <volume>76</volume>, <fpage>337</fpage>&#x2013;<lpage>347</lpage>. <pub-id pub-id-type="doi">10.1111/j.1432-0436.2007.00233.x</pub-id> </citation>
</ref>
<ref id="B34">
<citation citation-type="web">
<person-group person-group-type="author">
<name>
<surname>Wall</surname>
<given-names>I. B.</given-names>
</name>
<name>
<surname>Toledo</surname>
<given-names>G. S.</given-names>
</name>
<name>
<surname>Jat</surname>
<given-names>P. S.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>BioInsights - Recent Advances in Conditional Cell Immortalization Technology</article-title>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://www.insights.bio/immuno-oncology-insights/journal/article/481/recent-advances-in-conditional-cell-immortalization-technology">https://www.insights.bio/immuno-oncology-insights/journal/article/481/recent-advances-in-conditional-cell-immortalization-technology</ext-link>
</comment> (<comment>Accessed September 29, 2020</comment>). </citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Pei</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>A Prospect of Cell Immortalization Combined with Matrix Microenvironmental Optimization Strategy for Tissue Engineering and Regeneration</article-title>. <source>Cell Biosci</source> <volume>9</volume>, <fpage>7</fpage>. <pub-id pub-id-type="doi">10.1186/s13578-018-0264-9</pub-id> </citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weinrich</surname>
<given-names>S. L.</given-names>
</name>
<name>
<surname>Pruzan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ouellette</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tesmer</surname>
<given-names>V. M.</given-names>
</name>
<name>
<surname>Holt</surname>
<given-names>S. E.</given-names>
</name>
<etal/>
</person-group> (<year>1997</year>). <article-title>Reconstitution of Human Telomerase with the Template RNA Component hTR and the Catalytic Protein Subunit hTRT</article-title>. <source>Nat. Genet.</source> <volume>17</volume>, <fpage>498</fpage>&#x2013;<lpage>502</lpage>. <pub-id pub-id-type="doi">10.1038/ng1297-498</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>